metlife inc. - MET
MET
Close Chg Chg %
85.21 1.49 1.75%
Open Market
86.70
+1.49 (1.75%)
Volume: 1.14M
Last Updated:
Nov 22, 2024, 1:02 PM EDT
Company Overview: metlife inc. - MET
MET Key Data
| Open $84.99 | Day Range 84.79 - 86.74 |
| 52 Week Range 62.16 - 86.95 | Market Cap $58.99B |
| Shares Outstanding 692.42M | Public Float 579.87M |
| Beta 1.04 | Rev. Per Employee N/A |
| P/E Ratio 17.18 | EPS $5.00 |
| Yield 250.03% | Dividend $0.55 |
| EX-DIVIDEND DATE Nov 5, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 3.32M |
MET Performance
| 1 Week | -0.88% | ||
| 1 Month | 0.25% | ||
| 3 Months | 11.11% | ||
| 1 Year | 29.98% | ||
| 5 Years | 66.53% |
MET Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
18
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 93.308 | |
| Number of Ratings | 18 | Current Quarters Estimate | 2.236 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 8.321 | |
| Last Quarter’s Earnings | 1.95 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 7.25 | Next Fiscal Year Estimate | 9.705 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 14 | 13 | 14 | 14 |
| Mean Estimate | 2.24 | 2.16 | 8.32 | 9.70 |
| High Estimates | 2.39 | 2.28 | 8.62 | 9.95 |
| Low Estimate | 2.04 | 2.03 | 8.10 | 9.45 |
| Coefficient of Variance | 5.14 | 3.19 | 1.74 | 1.69 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 12 | 12 | 12 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 5 | 6 | 6 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Metlife Inc. - MET
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Metlife Inc. - MET
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 4, 2024 | Cheryl W. Grisé Director | 86,006 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.78 per share | 7,033,570.68 |
| Oct 4, 2024 | Mark Alan Weinberger Director | 15,270 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 4, 2024 | Jeh Charles Johnson Director | 5,036 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.78 per share | 411,844.08 |
| Oct 4, 2024 | Diana L. McKenzie Director | 20,000 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.78 per share | 1,635,600.00 |
| Oct 4, 2024 | Laura J. Hay Director | 2,010 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.78 per share | 164,377.80 |
| Oct 4, 2024 | Carla A. Harris Director | 6,785 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.78 per share | 554,877.30 |
| Oct 4, 2024 | David Lawrence Herzog Director | 25,300 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 4, 2024 | Robert Glenn Hubbard Director | 95,831 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.78 per share | 7,837,059.18 |
| Oct 4, 2024 | William E. Kennard Director | 41,102 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.78 per share | 3,361,321.56 |
| Oct 4, 2024 | Edward Joseph Kelly Director | 35,291 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.78 per share | 2,886,097.98 |
| Oct 4, 2024 | Carlos Miguel Gutierrez Director | 22,214 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 4, 2024 | Denise M. Morrison Director | 31,180 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 14, 2024 | Catherine R. Kinney Director | 61,815 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $69.06 per share | 4,268,943.90 |
| Jun 14, 2024 | Gerald L. Hassell Director | 31,442 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $69.06 per share | 2,171,384.52 |
| Mar 21, 2024 | William Pappas EVP, Global Tech. & Ops. | 57,768 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $72.27 per share | 4,174,893.36 |
| Mar 15, 2024 | Ramy Tadros President, U.S. Business | 146,981 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $71.9 per share | 10,567,933.90 |
| Mar 6, 2024 | Michel A. Khalaf President & CEO; Director | 495,587 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.73 per share | 34,557,281.51 |
| Mar 6, 2024 | Susan M. Podlogar EVP & Chief HR Officer | 79,794 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.73 per share | 5,564,035.62 |
| Mar 6, 2024 | John D. McCallion EVP & Chief Financial Officer | 204,781 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.73 per share | 14,279,379.13 |
| Mar 6, 2024 | Tamara L. Schock EVP & Chief Accounting Officer | 20,134 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $69.73 per share | 1,403,943.82 |
Metlife Inc. in the News
Wall Street CEOs demand Biden and Congress fix NYC migrant crisis
More than 100 CEOs and business leaders in New York City are calling for federal action to fix the United States' broken immigration system and address the migrant crisis.